成功早期应用体外膜肺氧合支持一名患有严重恶性高热和心脏骤停患者的心肺复苏：一例报告
Successful early application of extracorporeal membrane oxygenation to support cardiopulmonary resuscitation for a patient suffering from severe malignant hyperthermia and cardiac arrest: a case report.
作者信息
Huh Hyub, Jung Jae Seung, Park Sang Jae, Park Min Kyung, Lim Choon Hak, Yoon Seung Zhoo
机构信息
Department of Anesthesiology and Pain Medicine, Korea University College of Medicine, Seoul, Korea.
Department of Thoracic and Cardiovascular Surgery, Korea University College of Medicine, Seoul, Korea.
出版信息
Korean J Anesthesiol. 2017 Jun;70(3):345-349. doi: 10.4097/kjae.2017.70.3.345. Epub 2017 Feb 3.
Abstract
Malignant hyperthermia (MH) may lead to metabolic crisis of skeletal muscle in susceptible individuals following exposure to triggering agents such as volatile anesthetics or depolarizing muscle relaxants. MH is a rare and a potentially lethal disease, which can lead to cardiac arrest. We report a case of severe MH, in which the rapidly evolving signs of hypermetabolism eventually resulted in cardiac arrest. Despite conventional treatments following cardiopulmonary resuscitation, the patient's vital signs did not improve. Therefore, we applied extracorporeal membrane oxygenation for providing hemodynamic support.
摘要
恶性高热（MH）可能会导致易感个体在接触触发剂（如挥发性麻醉剂或去极化肌肉松弛剂）后出现骨骼肌代谢危机。MH是一种罕见且可能致命的疾病，可导致心脏骤停。我们报告一例严重的MH病例，其中快速进展的高代谢体征最终导致心脏骤停。尽管在心肺复苏后进行了常规治疗，但患者的生命体征并未改善。因此，我们应用体外膜肺氧合来提供血流动力学支持。
相似文献
1
Successful early application of extracorporeal membrane oxygenation to support cardiopulmonary resuscitation for a patient suffering from severe malignant hyperthermia and cardiac arrest: a case report.
Korean J Anesthesiol. 2017 Jun;70(3):345-349. doi: 10.4097/kjae.2017.70.3.345. Epub 2017 Feb 3.
2
Almost-certain malignant hyperthermia during cardiopulmonary bypass: a case report and literature review.
Perfusion. 2019 Sep;34(6):490-494. doi: 10.1177/0267659119833230. Epub 2019 Mar 7.
3
Malignant hyperthermia deaths related to inadequate temperature monitoring, 2007-2012: a report from the North American malignant hyperthermia registry of the malignant hyperthermia association of the United States.
Anesth Analg. 2014 Dec;119(6):1359-66. doi: 10.1213/ANE.0000000000000421.
4
Resuscitation and extracorporeal life support during cardiopulmonary resuscitation following the Norwood (Stage 1) operation.
Cardiol Young. 2011 Dec;21 Suppl 2:101-8. doi: 10.1017/S1047951111001673.
5
Survival outcomes after rescue extracorporeal cardiopulmonary resuscitation in pediatric patients with refractory cardiac arrest.
J Thorac Cardiovasc Surg. 2007 Oct;134(4):952-959.e2. doi: 10.1016/j.jtcvs.2007.05.054.
6
[Malignant hyperthermia--diagnostics, treatment and anaesthetic management].
Anasthesiol Intensivmed Notfallmed Schmerzther. 2009 Nov;44(11-12):758-63; quiz 764. doi: 10.1055/s-0029-1242125. Epub 2009 Nov 16.
7
Extracorporeal cardiopulmonary resuscitation for post-operative cardiac arrest: indications, techniques, controversies, and early results--what is known (and unknown).
Cardiol Young. 2011 Dec;21 Suppl 2:109-17. doi: 10.1017/S1047951111001685.
8
Cardiac extracorporeal life support: state of the art in 2007.
Cardiol Young. 2007 Sep;17 Suppl 2:104-15. doi: 10.1017/S1047951107001217.
9
Saving life and brain with extracorporeal cardiopulmonary resuscitation: A single-center analysis of in-hospital cardiac arrests.
J Thorac Cardiovasc Surg. 2015 Nov;150(5):1344-9. doi: 10.1016/j.jtcvs.2015.07.061. Epub 2015 Jul 26.
10
Cardiac arrest with refractory ventricular fibrillation: a successful resuscitation using extracorporeal membrane oxygenation.
Am J Emerg Med. 2013 Jan;31(1):264.e1-2. doi: 10.1016/j.ajem.2012.03.035. Epub 2012 May 23.
引用本文的文献
1
Malignant hyperthermia and dantrolene sodium.
Korean J Anesthesiol. 2019 Feb;72(1):78-79. doi: 10.4097/kja.d.18.00139. Epub 2018 Jun 20.
2
Combination of extracorporeal membrane oxygenation and inline hemofiltration for the acute hyperkalemic cardiac arrest in a patient with Duchenne muscular dystrophy following orthopedic surgery -a case report.
Korean J Anesthesiol. 2019 Apr;72(2):178-183. doi: 10.4097/kja.d.17.00075. Epub 2018 May 9.
本文引用的文献
1
The changing face of malignant hyperthermia: less fulminant, more insidious.
Anaesth Intensive Care. 2015 Jul;43(4):506-11. doi: 10.1177/0310057X1504300415.
2
Essential Role of Calmodulin in RyR Inhibition by Dantrolene.
Mol Pharmacol. 2015 Jul;88(1):57-63. doi: 10.1124/mol.115.097691. Epub 2015 Apr 28.
3
Management of malignant hyperthermia: diagnosis and treatment.
Ther Clin Risk Manag. 2014 May 14;10:355-62. doi: 10.2147/TCRM.S47632. eCollection 2014.
4
Delayed onset malignant hyperthermia after sevoflurane.
Case Rep Anesthesiol. 2013;2013:712710. doi: 10.1155/2013/712710. Epub 2013 May 30.
5
Extracorporeal Life Support Organization Registry Report 2012.
ASAIO J. 2013 May-Jun;59(3):202-10. doi: 10.1097/MAT.0b013e3182904a52.
6
Malignant hyperthermia: clinical and molecular aspects.
Rev Bras Anestesiol. 2012 Nov-Dec;62(6):820-37. doi: 10.1016/S0034-7094(12)70182-4.
7
Evolution of critical care cardiology: transformation of the cardiovascular intensive care unit and the emerging need for new medical staffing and training models: a scientific statement from the American Heart Association.
Circulation. 2012 Sep 11;126(11):1408-28. doi: 10.1161/CIR.0b013e31826890b0. Epub 2012 Aug 14.
8
Contemporary extracorporeal membrane oxygenation for adult respiratory failure: life support in the new era.
Intensive Care Med. 2012 Feb;38(2):210-20. doi: 10.1007/s00134-011-2439-2. Epub 2011 Dec 7.
9
Extracorporeal membrane oxygenation to support cardiopulmonary resuscitation: Useful, but for whom?
Crit Care Med. 2011 Jan;39(1):190-1. doi: 10.1097/CCM.0b013e318202e658.
10
Dantrolene, a therapeutic agent for malignant hyperthermia, markedly improves the function of failing cardiomyocytes by stabilizing interdomain interactions within the ryanodine receptor.
J Am Coll Cardiol. 2009 May 26;53(21):1993-2005. doi: 10.1016/j.jacc.2009.01.065.
Zotero 插件